Skip to main content
. 2024 Feb 27;14:4775. doi: 10.1038/s41598-024-55516-5

Figure 4.

Figure 4

NuS treatment enhances cell number, viability, and size compared to FBS and SF treatments. (A) Cell counts (B), viability, and (C) size were measured on days 2, 4, and 6 (n = 6 biological replicates). (**p ≤ 0.01, ***p ≤ 0.001, ****p ≤ 0.0001). Data are analyzed with Two-way ANOVA followed by Tukey’s multiple comparison test and unpaired t-test and are represented as mean ± SEM. *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001, ****p ≤ 0.0001.